(Q38221329)

31 August 2017

title

Warfarin pharmacogenetics: to genotype or not to genotype, that is the question (English)

1 reference

31 August 2017

1 reference

L H Cavallari

1

1 reference

31 August 2017

E A Nutescu

series ordinal

2

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

Clinical Pharmacology & Therapeutics

31 August 2017

published in

1 reference

31 August 2017

volume

96

1 reference

31 August 2017

issue

1

1 reference

31 August 2017

page(s)

22-24

1 reference

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.78

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.78

A randomized trial of genotype-guided dosing of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.78

A pharmacogenetic versus a clinical algorithm for warfarin dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.78

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.78

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.78

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.78

Genetic and clinical predictors of warfarin dose requirements in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.78

Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.78

Feasibility of implementing a comprehensive warfarin pharmacogenetics service

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.78

21 January 2018

Identifiers

DOI

10.1038/CLPT.2014.78

1 reference

31 August 2017

1 reference